How should low central venous pressure be maintained during liver resection (hepatectomy)?

How to Maintain Low CVP During Hepatectomy

Maintain CVP below 5 cm H₂O during hepatic transection through fluid restriction combined with pharmacologic interventions, using balanced crystalloids (Ringer's lactate) as maintenance fluid while avoiding excessive crystalloid or colloid administration. 1

Target CVP and Monitoring

The 2023 ERAS Society guidelines provide a strong recommendation (high evidence) to maintain CVP below 5 cm H₂O specifically during the hepatic transection phase 1. This target is supported by multiple RCTs demonstrating significant blood loss reduction—one trial showed blood loss of 188 mL in the low CVP group versus 346 mL in controls 2, while another demonstrated 672 mL versus 1,663 mL 3.

Key Monitoring Consideration

Consider transitioning from CVP to stroke volume variation (SVV) monitoring, as an RCT in laparoscopic hepatectomy showed SVV-guided management reduced both conversion rates and blood loss compared to CVP monitoring 1.

Practical Techniques to Achieve Low CVP

1. Fluid Restriction (Primary Method)

• Limit crystalloid administration before and during liver resection
• Use balanced crystalloids (Ringer's lactate) as maintenance fluid—NOT 0.9% saline 1
• Avoid excessive crystalloid administration as aggressively as you avoid blood loss 1

2. Pharmacologic Interventions

When fluid restriction alone is insufficient:

• Nitroglycerin infusion (continuous) to reduce venous return 3
• Esmolol infusion (continuous) for heart rate control 3
• Milrinone has shown superior results: better surgical field quality, less blood loss (142 mL vs 378 mL), reduced vasopressor requirements, and faster postoperative recovery 4

3. Positional Adjustments

• Manipulate patient positioning to reduce venous return 5
• Maintain systolic blood pressure >90 mmHg throughout 5

Critical Safety Parameters

Do NOT compromise these endpoints while maintaining low CVP:

• Systolic blood pressure must remain ≥90 mmHg 5
• Urine output should stay ≥20 mL/hour 3
• If SBP drops <90 mmHg for >1 minute more than 3 times, give 200 mL crystalloid bolus rapidly 3
• Administer ephedrine if SBP <90 mmHg for 1 minute 3

Timing: When to Apply and When to Stop

Apply low CVP: Specifically during hepatic parenchymal transection 1

Restore normal perfusion: Immediately after liver resection is complete, use goal-directed fluid therapy (GDFT) targeting adequate cardiac output and end-organ perfusion 1. This restoration phase is particularly critical for patients with comorbidities or reduced cardiac function 1.

Evidence-Based Outcomes

Low CVP technique demonstrates:

• Reduced blood loss: Meta-analysis of 1,285 patients showed 311.92 mL less blood loss 6
• Decreased transfusion: Both volume (158.85 mL less) and number of patients requiring transfusion (RR 0.41) 6
• No adverse effects: No increase in renal dysfunction, air embolism, or postoperative complications 5, 7, 6
• Improved liver function: Lower ALT levels in first 5 postoperative days 6
• Shorter hospital stay: 16.3 days versus 21.5 days 5

Common Pitfalls to Avoid

1. Excessive postoperative fluid: Weight gain >3.5 kg on postoperative day 2 independently predicts major complications—monitor and minimize postoperative weight fluctuation 1

2. Using 0.9% saline: Always use balanced crystalloids instead 1

3. Maintaining low CVP throughout entire surgery: Only apply during transection; restore perfusion afterward 1

4. Ignoring hemodynamic instability: Have clear rescue protocols for hypotension and oliguria 3, 5